Somalogic Inc (SLGC) - Total Liabilities
Based on the latest financial reports, Somalogic Inc (SLGC) has total liabilities worth $68.31 Million USD as of September 2023. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Somalogic Inc - Total Liabilities Trend (2019–2022)
This chart illustrates how Somalogic Inc's total liabilities have evolved over time, based on quarterly financial data. See Somalogic Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Somalogic Inc Competitors by Total Liabilities
The table below lists competitors of Somalogic Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Delcath Systems Inc
NASDAQ:DCTH
|
USA | $12.13 Million |
|
Timbercreek Financial Corp
TO:TF
|
Canada | CA$1.42 Billion |
|
Shanghai Lujiazui Finance & Trade Zone Development Co Ltd B
SHG:900932
|
China | $117.92 Billion |
|
Anhui Shiny Electronic Technology Company Limited
SHE:300956
|
China | CN¥1.82 Billion |
|
ATN International Inc
NASDAQ:ATNI
|
USA | $1.04 Billion |
|
Channel Well Technology Co Ltd
TWO:3078
|
Taiwan | NT$2.90 Billion |
|
Genesco Inc
NYSE:GCO
|
USA | $831.59 Million |
|
Ehang Holdings Ltd
NASDAQ:EH
|
USA | $936.72 Million |
Liability Composition Analysis (2019–2022)
This chart breaks down Somalogic Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see SLGC market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 17.79 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.14 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Somalogic Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Somalogic Inc (2019–2022)
The table below shows the annual total liabilities of Somalogic Inc from 2019 to 2022.
| Year | Total Liabilities | Change |
|---|---|---|
| 2022-12-31 | $84.82 Million | -9.85% |
| 2021-12-31 | $94.08 Million | +66.88% |
| 2020-12-31 | $56.37 Million | +10.88% |
| 2019-12-31 | $50.84 Million | -- |
About Somalogic Inc
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for its cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in … Read more